Published • loading... • Updated
Sagent Launches Bludigo®, an Indigo Carmine Injection, Through New Partnership with Provepharm
Sagent partners with Provepharm to launch Bludigo, the first FDA-approved indigo carmine dye for ureter evaluation, entering the $200 million U.S. diagnostic dye market.
Summary by PR Newswire
10 Articles
10 Articles
+9 Reposted by 9 other sources
Sagent Launches Bludigo®, an Indigo Carmine Injection, Through New Partnership with Provepharm
Launch Marks Entry into Diagnostic Dye Market
·Parsons, United States
Read Full ArticleCoverage Details
Total News Sources10
Leaning Left0Leaning Right1Center5Last UpdatedBias Distribution83% Center
Bias Distribution
- 83% of the sources are Center
83% Center
C 83%
R 17%
Factuality
To view factuality data please Upgrade to Premium





